PM14 for Solid Tumors
This trial is testing a new combination regimen for patients with advanced solid tumors.
- Advanced Solid Tumors
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
How many research subjects are needed for this experiment?
"Yes, if you visit clinicaltrials.gov you'll see that this research is actively looking for test subjects. The original posting was on September 6th, 2017, and the listing was updated on May 23rd, 2020. They need a total of 150 people for the study, which will be conducted at 2 locations."
What is the primary objective of this clinical trial?
"The main objective of this study is to measure the effect of the medication on patients with dose-limiting toxicities. Secondary objectives include Clinical Benefit Rate, Progression-free Survival, and Duration of Response."
Does PM14 have the seal of approval from the FDA?
"PM14 falls into the Phase 1 category, which means that not much is known about its safety or efficacy. Our team at Power gives it a 1 out of 3."